Inquis Medical raised $40M in a Series B financing led by Marshall Wace to advance the Aventus Thrombectomy System for venous thromboembolic diseases.

Nov 04, 2024•about 1 year ago

Amount Raised

$40 Million

Round Type

series b

Menlo ParkMedical DeviceMedicalBiotechnologyHealth Care

Investors

Pierre LamondEn Pointe VenturesYu StarShang Bay CapitalMarshall Wace

Description

Inquis Medical has successfully closed a $40 million Series B financing round, led by Marshall Wace. This funding will help accelerate the development and commercialization of their advanced thrombectomy technologies.

Company Information

Company

Inquis Medical

Location

Menlo Park, California, United States

About

Inquis Medical is a clinical-stage medical device company focused on peripheral vascular innovations. The company is developing next generation thrombectomy technology that offers physicians improved control and precision, enhances procedural efficiency, and minimizes blood loss. Founded in 2020, Inquis Medical is led by a seasoned executive team with over three decades of combined experience in developing, launching, and supporting novel medical devices that address unmet clinical needs and deliver lasting impact.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends